Finance

Lists
Why is CLS down 11,76%?
Dive Deeper
CLS:NYSE
Celestica Inc
USD 208,62
-11,76%
(-27,80) 1D
5 Nov., 15:16:44 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLS...
Open
USD 223,07
High
USD 225,93
Low
USD 197,50
Mkt. cap
26,29 mjd
Avg. vol.
2,81 m
Volume
5,62 m
P/E ratio
19,73
52-wk high
USD 474,02
52-wk low
USD 197,50
EPS
USD 10,57
Beta
2,11
Shares outstanding
126,11 m
No. of employees
24 k
Open
USD 223,07
High
USD 225,93
Low
USD 197,50
Mkt. cap
26,29 mjd
Avg. vol.
2,81 m
Volume
5,62 m
P/E ratio
19,73
52-wk high
USD 474,02
52-wk low
USD 197,50
EPS
USD 10,57
Beta
2,11
Shares outstanding
126,11 m
No. of employees
24 k
News stories
From web sources and news partners
Profile
Celestica Inc. is a Canadian multinational design, manufacturing, hardware platform, and supply chain electronics manufacturing services company, which is headquartered in Toronto, Ontario. The company operates in 50 sites across 15 countries. Wikipedia
About Celestica Inc
CEORobert A. Mionis
Employees23,8 k
Founded1994
HeadquartersToronto, Ontario, Kanada
SectorInformation Technology
IndustryElectronics manufacturing services
Analyst ratings
Based on 15 analysts giving stock ratings to CLS in the past 3 months
Strong buy
Buy
15
Hold
0
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for CLS in the last 3 months.
Highest
Current USD 208,62
USD 535,00 (+156,45%)
Average
USD 461,87 (+121,39%)
Lowest
USD 375,00 (+79,75%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ruplu Bhattacharya
Bank of America Securities
Buy
Reiterated
USD 450,00
+115,7%
11/04/2026
Todd Coupland
CIBC
Buy
Maintained
USD 500,00
+139,7%
10/29/2026
Joseph Cardoso
J.P. Morgan
Buy
Maintained
USD 485,00
+132,5%
10/28/2026
Paul Treiber
RBC Capital
Buy
Maintained
USD 450,00
+115,7%
10/27/2026
John Shao
TD Cowen
Buy
Reiterated
USD 430,00
+106,1%
10/28/2026
David Vogt
UBS
Buy
Reiterated
USD 453,00
+117,1%
10/28/2026
Mehdi Hosseini
Susquehanna
Buy
Reiterated
USD 535,00
+156,4%
10/27/2026
Thanos Moschopoulos
BMO Capital
Buy
Maintained
USD 400,00
+91,7%
10/28/2026
Atif Malik
Citi
Buy
Maintained
USD 436,00
+109%
10/28/2026
Michael Ng
Goldman Sachs
Buy
Maintained
USD 480,00
+130,1%
10/26/2026
Ruben Roy
Stifel Nicolaus
Buy
Reiterated
USD 500,00
+139,7%
10/28/2026
Kevin Krishnaratne
Scotiabank
Buy
Reiterated
USD 500,00
+139,7%
10/29/2026
Tim Long
Barclays
Buy
Maintained
USD 414,00
+98,4%
10/28/2026
Daniel Zhu‏
Bernstein
Buy
Maintained
USD 520,00
+149,3%
10/26/2026
Unknown Analyst
Bernstein
Buy
Initiated
CAD 520,00
+149,3%
09/30/2026
Chris Krueger CFA
TD Cowen
Buy
Maintained
USD 430,00
+106,1%
09/16/2026
Shebly Seyrafi
FBN Securities
Buy
Initiated
USD 375,00
+79,8%
09/15/2026
Jim Kelleher
Argus Research
Buy
Reiterated
USD 450,00
+115,7%
07/28/2026
Unknown Analyst
Argus Research
Buy
Reiterated
USD 450,00
+115,7%
07/28/2026
George Notter
Wolfe Research
Buy
Reiterated
USD 475,00
+127,7%
07/28/2026
Nilesh Bhaiya
Citi
Buy
Maintained
USD 475,00
+127,7%
05/26/2026
Mike Ng
Goldman Sachs
Buy
Maintained
USD 475,00
+127,7%
05/26/2026
Mike Harrison
Rothschild & Co Redburn
Buy
Initiated
USD 460,00
+120,5%
05/01/2026
Samik Chatterjee
J.P. Morgan
Buy
Reiterated
USD 425,00
+103,7%
04/29/2026
Unknown Analyst
Canaccord Genuity
Buy
Maintained
USD 500,00
+139,7%
04/29/2026
Last report
27 Okt. 2026
Fiscal period
Q3 2026
USD 3,30 / USD 2,96
+11,50%beat
Revenue / Est. (USD)
5,83 mjd / 5,47 mjd
+6,66%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Des. 2025
Mrt. 2026
Jun. 2026
Sep. 2026
Revenue
3,65 mjd
4,05 mjd
4,70 mjd
5,83 mjd
Cost of goods sold
3,22 mjd
3,61 mjd
4,12 mjd
5,19 mjd
Cost of revenue
3,22 mjd
3,61 mjd
4,12 mjd
5,19 mjd
Research and development expenses
30,20 m
41,20 m
46,30 m
51,20 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
71,30 m
117,20 m
58,00 m
118,00 m
Operating expense
114,90 m
169,30 m
116,20 m
179,70 m
Total operating expenses
3,34 mjd
3,78 mjd
4,24 mjd
5,37 mjd
Operating income
318,20 m
267,90 m
461,30 m
461,10 m
Other non operating income
-
-
-
-
EBT including unusual items
301,30 m
256,30 m
441,60 m
455,80 m
EBT excluding unusual items
304,60 m
251,90 m
443,90 m
456,70 m
Income tax expense
33,80 m
44,00 m
72,80 m
58,60 m
Effective tax rate
11,22%
17,17%
16,49%
12,86%
Other operating expenses
1,40 m
-
-
-
Net income
267,50 m
212,30 m
368,80 m
397,20 m
Net profit margin
7,32%
5,25%
7,85%
6,81%
Earnings per share
1,89
2,16
2,54
3,30
Interest and investment income
-
-
3,80 m
19,70 m
Interest expense
-13,60 m
-16,00 m
-21,20 m
-24,10 m
Net interest expenses
-13,60 m
-16,00 m
-17,40 m
-4,40 m
Depreciation and amortization charges
-
-
-
-
EBITDA
370,90 m
307,50 m
505,30 m
509,60 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google-programme